INTECH INVESTMENT MANAGEMENT LLC - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 306 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.2%.

Quarter-by-quarter ownership
INTECH INVESTMENT MANAGEMENT LLC ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$1,907,761
-24.5%
50,510
-11.6%
0.01%
-26.3%
Q3 2022$2,527,00057,1400.02%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
BB BIOTECH AG 6,529,838$404,393,00011.39%
DOWLING & YAHNKE LLC 676,379$41,888,0005.27%
Opus Point Partners Management, LLC 102,459$6,345,0004.19%
WILLIAM HARRIS INVESTORS INC 230,443$14,271,0003.43%
PINNACLE ASSOCIATES LTD 1,690,263$104,678,0002.20%
MESSNER & SMITH THEME VALUE INVESTMENT MANAGEMENT LTD /CA/ 21,298$1,319,0002.11%
Sonora Investment Management, LLC 126,763$7,850,0002.04%
Virtus ETF Advisers LLC 10,447$647,0001.78%
Apex Capital Management 1,020,096$63,175,0001.41%
PERKINS CAPITAL MANAGEMENT INC 19,900$1,232,0001.32%
View complete list of IONIS PHARMACEUTICALS INC shareholders